株式会社極東書店トップ商品一覧Pharmaceutical Computer Systems Validation: Volume 2 - Real Life Case Studies. 3rd edition

商品詳細

Pharmaceutical Computer Systems Validation: Volume 2 - Real Life Case Studies. 3rd edition

Pharmaceutical Computer Systems Validation: Volume 2 - Real Life Case Studies. 3rd edition

・ISBN 978-1-041-37114-4 paper GB£ 51.99

¥16,470.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
電子版あり 大学・学術機関向け電子ブック(eBook)ISBN 9781042006175
著者・編者Wingate, Guy (ed.),
シリーズ (Drugs and the Pharmaceutical Sciences)
出版社 (CRC Press, UK)
出版年月2027
ページ数488 pp.
言語ENG
ニュース番号<A05-73158>

解説

Computerized systems play a fundamental role in the development, manufacture and supply of medical treatments. This is the third and thoroughly updated edition of the best-selling book dealing with validation, compliance and software in the pharmaceutical, healthcare and medical device industries. The first volume provides a comprehensive walk-through of lifecycle and development methodologies bringing together technological advances, latest regulatory requirements, inspection findings, and compliance strategies. New chapters have been added on agile development methodologies, data integrity, artificial intelligence and machine learning. The second volume comprises an extensive set of refreshed case studies spanning laboratory, manufacturing and supply chain systems with new contributions on databases, spreadsheets, LIMS, blockchain, mobile devices, AI-enabled systems, big data and digital twins authored by various industry experts.

Key Features

  • Covers governance framework, roles and responsibilities, quality culture, project lifecycle, operational compliance, risk management, electronic records/signatures, supplier management, practical troubleshooting, handling regulatory inspections, metrics, and the opportunity for performance improvement
  • Provides a set of 22 new and updated case studies by industry experts, demonstrating how these computer system validation principles are put into practice
  • Focuses on GxP regulatory requirements covering GCPs, GLPs, GMPs, and GDPs-complete with observations from inspections by the US FDA and other regulators
  • Discusses industry regulations and guidance, including current thinking of the US FDA on computer software assurance, the latest guidance from the US FDA/EU/MHRA on data integrity, and the newly published ISPE GAMP 5 Guide (Second Edition)
  • Shares the practical experience and advice from a group of leading computer validation and compliance international experts